quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·141d
PRRelease
LivaNova PLC logo

LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting

LIVN· LivaNova PLC
Health Care
Original source

Companies

  • LIVN
    LivaNova PLC
    Health Care

Recent analyst ratings

  • Dec 19UpdateKeyBanc Capital Markets$81.00
  • Oct 1UpdateGoldman$55.00
  • May 20UpdateWolfe Research$60.00
  • Feb 26UpdateWolfe Research-
  • Oct 4UpdateGoldman$65.00
  • Sep 17UpdateRobert W. Baird$66.00

Related

  • PR3d
    Annals of Internal Medicine Publishes 12-Month Results from LivaNova's OSPREY Clinical Study for Obstructive Sleep Apnea
  • INSIDER22d
    SEC Form 4 filed by Tezel Ahmet
  • INSIDER22d
    SEC Form 4 filed by Poletti Franco
  • INSIDER22d
    SEC Form 4 filed by Makatsaria Vladimir
  • INSIDER22d
    SEC Form 4 filed by Shvartsburg Alex
  • INSIDER22d
    SEC Form 4 filed by Bolton Stephanie
  • INSIDER22d
    SEC Form 4 filed by Kozmina Natalia
  • PR27d
    MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022